Boston Scientific Stock News

MARLBOROUGH, Mass., Feb. 14, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in SVB Leerink's 11th Annual Global Healthcare Conference on Thursday, February 17, 2022.

Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Union Pacific Corporation (UNP), and Freeport-McMoRan Inc. (FCX).

Spanish stocks traded higher this morning, with the IBEX 35 Index surging to the strongest level in over two weeks. Investors, meanwhile, focused on some notable insider trades. When insiders sell sha

Las Vegas, USA, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Ureteroscope Market Anticipated to Witness a Significant CAGR of 5.47% by 2026, Estimates DelveInsight The growing demand for Ureteroscope Market is primarily attributed to the growing prevalence of urolithiasis or nephrolithiasis accompanied by the rising burden of obesity which is a risk factor for the development of kidney stones, and the entrance of key pharma players such as Olympus, Stryker, Boston Scientific Corporation, Richard Wolf GmbH, KARL STORZ in the Ureteroscope Market DelveInsight''s Ureteroscope Market Insights and Forecast report provides the current and forecast Ureteroscope, upcoming innovation in the devices, individual market shares of the devices, challenges, drivers and barriers, market trends, and key competitors in the Ureteroscope Market scenario. Some of the essential takeaways from the Ureteroscope Market report: According to DelveInsight analysis, North America is expected to dominate the overall Ureteroscope Market during the forecasted period.

Over the past 3 months, 5 analysts have published their opinion on Boston Scientific (NYSE: BSX ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company''s business to predict how a stock will trade over the upcoming year. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 2 1 0 0 Last 30D 1 1 1 0 0 1M Ago 0 0 0 0 0 2M Ago 1 1 0 0 0 3M Ago 0 0 0 0 0 In the last 3 months, 5 analysts have offered 12-month price targets for Boston Scientific. The company has an average price target of $49.8 with a high of $53.00 and a low of Full story available on Benzinga.com

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.

BSX earnings call for the period ending December 31, 2021.

BSX earnings call for the period ending December 31, 2021.

Boston Scientific (BSX) registers a year-over-year improvement in organic sales, indicating a strong rebound in legacy business from pandemic mayhem.

Boston Scientific (BSX) registers a year-over-year improvement in organic sales, indicating a strong rebound in legacy business from pandemic mayhem.

These are the stocks posting the largest moves before the bell.

Boston Scientific Corporation (BSX) CEO Mike Mahoney on Q4 2021 Results - Earnings Call Transcript

Boston Scientific (BSX) shares are trading 3.9% lower premarket despite reporting consensus beating Q4 2021 results.Net sales grew 15.4% Y/Y to $3.13B, ahead of forecast of…